EGFR and neoplasm: In this study we investigated the detection of metabolites of hyperpolarized [1-13C]pyruvate with regard to monitoring treatment response using 213Bi-anti-EGFR-MAb (the alpha-emitter 213Bi coupled to an anti-EGFR antibody) in an in vitro system using LN18 and EJ28Luc tumor cells.